Aurobindo Pharma Ltd

aurobindo.com BSE: 524804 NSE : AUROPHARMA
About [ edit ]

Aurobindo Pharma is principally engaged in manufacturing and marketing of active pharmaceutical ingredients, generic pharmaceuticals and related services.(Source : 202003 Annual Report Page No:159)

Website BSE NSE
  • Market Cap ₹ 58,986 Cr.
  • Current Price ₹ 1,007
  • High / Low ₹ 1,064 / 655
  • Stock P/E 11.0
  • Book Value ₹ 313
  • Dividend Yield 0.40 %
  • ROCE 18.7 %
  • ROE 18.4 %
  • Face Value ₹ 1.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company's median sales growth is 18.07% of last 10 years

Cons

  • Company might be capitalizing the interest cost
  • Earnings include an other income of Rs.3161.47 Cr.

Peer comparison

Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs & Formln

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2018 Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020
4,049 4,250 4,751 5,270 5,292 5,445 5,600 5,895 6,158 5,925 6,483 6,365
3,261 3,539 3,765 4,183 4,235 4,298 4,460 4,688 4,862 4,679 5,071 5,011
Operating Profit 788 711 986 1,086 1,057 1,146 1,140 1,207 1,297 1,245 1,412 1,354
OPM % 19% 17% 21% 21% 20% 21% 20% 20% 21% 21% 22% 21%
Other Income 44 44 -0 41 -4 8 8 18 45 116 54 2,947
Interest 25 30 35 48 50 50 41 37 32 21 16 19
Depreciation 157 155 164 163 187 241 243 250 232 256 257 277
Profit before tax 651 571 787 917 816 863 864 938 1,078 1,084 1,193 4,005
Tax % 19% 20% 22% 22% 28% 26% 26% 25% 21% 28% 32% 26%
Net Profit 529 456 611 712 585 636 640 705 850 781 806 2,946
EPS in Rs 9.02 7.78 10.44 12.16 9.99 10.85 10.92 12.04 14.50 13.32 13.76 50.29
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 TTM
3,023 3,515 4,368 4,615 5,842 8,089 12,103 13,772 14,910 16,463 19,564 23,099 24,932
2,850 2,744 3,405 4,050 4,970 5,952 9,524 10,579 11,469 12,691 15,612 18,249 19,623
Operating Profit 173 772 963 565 873 2,137 2,579 3,193 3,441 3,772 3,952 4,849 5,309
OPM % 6% 22% 22% 12% 15% 26% 21% 23% 23% 23% 20% 21% 21%
Other Income 170 205 61 -300 17 18 81 200 115 105 70 166 3,161
Interest 93 73 65 277 267 310 160 257 67 78 263 305 88
Depreciation 128 149 172 201 249 313 333 392 428 558 668 967 1,022
Profit before tax 122 754 788 -213 374 1,533 2,168 2,744 3,061 3,241 3,091 3,743 7,360
Tax % 18% 25% 29% 42% 22% 24% 28% 26% 25% 25% 24% 24%
Net Profit 100 563 563 -124 294 1,173 1,576 2,025 2,302 2,423 2,365 2,831 5,383
EPS in Rs 1.87 10.11 9.68 -2.12 5.05 20.12 26.98 34.61 39.29 41.36 40.36 48.32 91.87
Dividend Payout % 24% 5% 10% -24% 15% 7% 8% 7% 6% 6% 6% 6%
Compounded Sales Growth
10 Years:21%
5 Years:14%
3 Years:16%
TTM:12%
Compounded Profit Growth
10 Years:18%
5 Years:12%
3 Years:7%
TTM:110%
Stock Price CAGR
10 Years:26%
5 Years:5%
3 Years:19%
1 Year:51%
Return on Equity
10 Years:23%
5 Years:22%
3 Years:20%
Last Year:18%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Corporate actions
Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Sep 2020
27 28 29 29 29 29 29 59 59 59 59 59 59
Reserves 1,214 1,801 2,416 2,311 2,577 3,721 5,127 7,229 9,313 11,622 13,832 16,752 18,283
Borrowings 2,333 2,155 2,414 3,096 3,435 3,769 4,451 5,041 3,364 4,770 6,967 5,826 5,211
650 804 1,009 798 1,232 1,970 3,303 3,568 3,464 4,492 5,414 6,126 6,935
Total Liabilities 4,224 4,787 5,868 6,234 7,273 9,490 12,910 15,896 16,200 20,942 26,271 28,763 30,488
1,399 1,711 1,739 2,195 2,639 2,722 3,706 4,180 4,834 6,521 8,475 9,396 9,516
CWIP 536 570 657 645 219 310 420 848 1,458 1,583 1,668 1,986 1,838
Investments 0 0 39 39 22 20 20 123 246 312 360 555 655
2,289 2,506 3,433 3,355 4,393 6,439 8,765 10,745 9,662 12,527 15,768 16,826 18,479
Total Assets 4,224 4,787 5,868 6,234 7,273 9,490 12,910 15,896 16,200 20,942 26,271 28,763 30,488

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
103 427 335 326 275 646 1,237 1,420 3,279 1,955 1,651 4,381
-406 -398 -603 -563 -246 -819 -1,017 -1,446 -1,787 -1,927 -2,904 -1,563
165 -84 407 119 108 118 93 365 -1,915 864 1,919 -1,947
Net Cash Flow -139 -55 139 -118 137 -55 313 340 -424 892 666 871

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2009 Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020
ROCE % 5% 22% 20% 8% 11% 27% 27% 27% 25% 23% 18% 19%
Debtor Days 107 99 103 98 100 119 107 122 68 68 64 68
Inventory Turnover 2.18 1.94 1.86 1.83 1.91 1.84 1.96 1.72 1.64 1.42 1.41 1.38

Shareholding Pattern

Numbers in percentages

Jun 2018 Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021
51.87 51.87 51.87 51.87 51.87 51.87 51.87 52.01 52.01 52.01 51.94 51.94
17.77 19.11 20.07 21.47 21.96 21.95 21.42 22.26 22.63 23.01 24.99 24.37
15.83 15.04 14.44 13.69 13.27 13.00 13.18 12.56 12.56 13.67 12.61 13.24
14.53 13.98 13.62 12.97 12.90 13.18 13.53 13.16 12.80 11.31 10.47 10.45

Documents

Recent announcements


View all

Annual reports

Credit ratings

Concalls